Jerry Yeo

Dr. Yeo brings over 33 years of clinical chemistry experience to the Truvian Scientific Advisory Board. Dr. Yeo is an academic clinical chemist and is board-certified in Clinical Chemistry (1990) & Toxicological Chemistry (1995) by the American Board of Clinical Chemistry. He was the Director of Clinical Chemistry & Endocrinology Laboratories, Dartmouth Reference Laboratory and Professor of Pathology at Dartmouth-Hitchcock Medical Center (1995-2007). Prior to that he was the Scientific Director of Clinical Chemistry and Endocrinology Laboratories and an Assistant Professor at Beth Israel Hospital & Harvard Medical School (1987-1995). Dr. Yeo was past-President of the Commission on Accreditation in Clinical Chemistry (2017-2018), past-Chair of the AACC Personalized Medicine Division (2017-2018), past Treasurer of the AACC Proteomics & Metabolomics Division (2015-2016), past-Chair of Chicago Section of AACC (2014-2015), past-Chair of the AACC Molecular Pathology Division (2008-2010), and past Vice-President of American Board of Clinical Chemistry (2003-2005). He is currently an Associate Editor (Clinical Chemistry Section) of the American Journal of Clinical Pathology. His research interests are in emerging angiogenic biomarkers, clinical mass spectrometry and clinical pharmacogenomics applications for precision medicine. He had published more than 100 original articles, book chapters and abstracts in the field of clinical chemistry and pharmacogenomics.